These factors are positioning GLP-1 therapies as a key component of chronic disease management across the U.S
Compounded Versions: Custom formulations available through licensed compounding pharmacies, which provide a tailored approach based on individual needs
Women who were pregnant, nursing, had other female sexual dysfunctions, or had recent psychiatric diagnoses or substance use issues were excluded from the studies
GLP-1 medications are approved for adults who have a body mass index (BMI) of 30 or higher, or a BMI of at least 27 plus a weight-related medical condition, such as the following: Type 2 diabetes High blood pressure High cholesterol Obstructive sleep apnea Cardiovascular disease that increases the risk of heart attack or stroke MASH, or metabolic dysfunctionassociated steatohepatitis, a form of liver inflammation Avlin Imaeda, MD, PhD, a Yale Medicine gastroenterologist who is board-certified in obesity medicine, notes that qualifying for the medication based on heart disease aloneoften necessary for insurance coveragecan be challenging